Everything we do at Oak Therapeutics is informed by thorough research. We therefore engage with external research partners, some of which are among the best in their fields. They help us to combine our technology expertise with the best available knowledge in medicine and patient care. We partner with institutions and individuals who believe in the mission of bringing affordable, high quality pharmaceuticals and nutraceuticals to underserved populations. Examples of our research collaborations include:



  • Kansas University Medical Center (KUMC): Joint NIH-funded research project on patient-centered development of an Oral Dissolvable Strip (ODS) for the treatment of HIV in infants and children.

  • National Institutes of Health (NIH) - National Institute of Allergy and Infectious Diseases (NIAID): Funded research for the development of an Isoniazid (INH) Oral Dissolvable Strip, an antibiotic used in the treatment of tuberculosis.

  • Children’s Hospital of Los Angeles: Development of antibiotics on Oral Dissolvable Strips (ODS) for pediatric cancer patients

  • University of Southern California: Absorption of Ivermectin on Oral Dissolvable Strips

  •  University of Washington:  Testing of an Aspirin Oral Dissolvable Strip for the emergency treatment of acute myocardial infarction.

  • Commercial client I: Development of an anti-emetic veterinary ODS

  • Commercial client II: Development of an ODS for the treatment of dry mouth in cancer patients.